Generation of cloned goats (Capra hircus) from transfected foetal fibroblast cells, the effect of donor cell cycle.
The neomycin-resistant gene (neo(r)) is probably the most commonly used selectable marker gene in gene targeting and gene transfection research. In this study, the neo(r) gene construct was introduced into in vitro cultured goat foetal fibroblast cells (IV-5), and the cells were selected with 900 microg/ml G418. The G418-resistant colonies were analysed by neo-specific PCR, karyotyping and anti-intermediate filament proteins antibody (anti-vimentin) staining. Cell cycle analysis of the neo(r) positive foetal fibroblast cell colony (IV-5.1) cultured in a variety of cell cycle-arresting medium indicated that 74.2% of cells cultured in serum-deprived medium for 3 days and 71.7% of cells grown to confluence were at G0/G1 stage of cell cycle, respectively, in comparison to 61.6% of cells in normal culture (cycling) medium. Nocodazole treatment for 17 hr in vitro culture could increase the number of cells at G2/M stage of cell cycle from 20.3% (in cycling medium) to 39.7%. In total, one early pregnancy was observed by B ultra-sound scanning in a surrogate transferred with cloned embryos from IV-5.1 cells at M stage (cells were cultured in nocodazole medium). Seven cloned goats, including two that miscarried at a late stage, were derived from the IV-5.1 cell clone cultured in starved medium (G0). Indeed, one surrogate receiving three blastocysts reconstituted from the starved donor cells, gave birth to three live cloned goats, all of which are healthy and doing well. PCR, Southern blot and G418 resistance in vitro of fibroblast cells from cloned goats confirmed that all cloned goats are positive for neo(r) transgene. This study demonstrates that a foreign gene, such as the neo-resistant gene, can be introduced into goat foetal fibroblast cells, and that the resulting transgenic cells are capable of being cloned to produce 100% transgenic animals.
Zou
Xiangang
X
The Babraham Institute, Babraham, Cambridge, United Kingdom.
Wang
Yuge
Y
Cheng
Yong
Y
Yang
Yuefei
Y
Ju
Huiming
H
Tang
Huilin
H
Shen
Yu
Y
Mu
Zongyao
Z
Xu
Shaofu
S
Du
Miao
M
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001755:Blastocyst / Q000187:drug effects / Q000502:physiology; D002453:Cell Cycle / Q000502:physiology*; D002460:Cell Line; D002469:Cell Separation; D019976:Cloning, Organism / Q000379:methods*; D004624:Embryo Transfer; D005260:Female; D005347:Fibroblasts / Q000502:physiology*; D005434:Flow Cytometry; D006041:Goats / Q000235:genetics*; D006801:Humans; D015739:Nocodazole / Q000494:pharmacology; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D030781:Organisms, Genetically Modified; D011247:Pregnancy; D014162:Transfection / Q000379:methods*
D000970:Antineoplastic Agents; D015739:Nocodazole